Distribution of Ventilation, Respiratory Drive and Gas Exchange: Measurements and Monitoring
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jul 15, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Non-smokers
- Exclusion Criteria:
- • \<18 years old
- • Significant history of pulmonary disease
- • Chest wall, anatomical, physical abnormalities, skin integrity issues precluding placement of electrode belt in direct contact with skin
- • Skin integrity issues precluding placement of nose clips, or transcutaneous carbon dioxide monitoring
- • Inability to form a seal around a mouthpiece
- • Known esophageal strictures, webs, or varices (if esophageal manometry to be included)
- • Known platelet count \< 100,000 (if esophageal manometry to be included)
- • On therapeutic anticoagulation (if esophageal manometry to be included)
- • Known multidrug resistant (MDR) pulmonary infection
- • Non-English language speakers
- • Chronic hypoxemic respiratory failure
- • Confirmed or suspected intracranial bleed, stroke, edema
- • Active implants (i.e. implantable electronic devices such as pacemakers, cardioverter defibrillators or neurostimulators) or if device compatibility is in doubt
- • Pregnant or lactating patients as safety and efficacy for use of EIT in such cases has not been verified
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Trial Officials
Alex Pearce
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials